Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12873539rdf:typepubmed:Citationlld:pubmed
pubmed-article:12873539lifeskim:mentionsumls-concept:C0018823lld:lifeskim
pubmed-article:12873539lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:12873539lifeskim:mentionsumls-concept:C0085149lld:lifeskim
pubmed-article:12873539lifeskim:mentionsumls-concept:C0032790lld:lifeskim
pubmed-article:12873539lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:12873539lifeskim:mentionsumls-concept:C0439836lld:lifeskim
pubmed-article:12873539pubmed:issue7lld:pubmed
pubmed-article:12873539pubmed:dateCreated2003-7-22lld:pubmed
pubmed-article:12873539pubmed:abstractTextTacrolimus is a potent calcineurin inhibitor that was introduced to heart transplantation in the early 1990s. The side-effect profile of tacrolimus is more favorable than that of cyclosporine and some reports have suggested an advantage of tacrolimus in the treatment of rejection. The present study was undertaken to determine whether a late conversion to tacrolimus affords these benefits to heart transplant recipients.lld:pubmed
pubmed-article:12873539pubmed:languageenglld:pubmed
pubmed-article:12873539pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:citationSubsetIMlld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12873539pubmed:statusMEDLINElld:pubmed
pubmed-article:12873539pubmed:monthJullld:pubmed
pubmed-article:12873539pubmed:issn1053-2498lld:pubmed
pubmed-article:12873539pubmed:authorpubmed-author:HuntSharon...lld:pubmed
pubmed-article:12873539pubmed:authorpubmed-author:CantinBernard...lld:pubmed
pubmed-article:12873539pubmed:authorpubmed-author:ValantineHann...lld:pubmed
pubmed-article:12873539pubmed:authorpubmed-author:ChanMichael...lld:pubmed
pubmed-article:12873539pubmed:authorpubmed-author:ShibaNobuyuki...lld:pubmed
pubmed-article:12873539pubmed:authorpubmed-author:KwokBernard...lld:pubmed
pubmed-article:12873539pubmed:issnTypePrintlld:pubmed
pubmed-article:12873539pubmed:volume22lld:pubmed
pubmed-article:12873539pubmed:ownerNLMlld:pubmed
pubmed-article:12873539pubmed:authorsCompleteYlld:pubmed
pubmed-article:12873539pubmed:pagination723-30lld:pubmed
pubmed-article:12873539pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:meshHeadingpubmed-meshheading:12873539...lld:pubmed
pubmed-article:12873539pubmed:year2003lld:pubmed
pubmed-article:12873539pubmed:articleTitlePost-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience.lld:pubmed
pubmed-article:12873539pubmed:affiliationDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA. clajoie@sympatico.calld:pubmed
pubmed-article:12873539pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12873539pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12873539pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12873539pubmed:publicationTypeEvaluation Studieslld:pubmed